Myofibrillar myopathy type 6 (MFM6) is a rare genetic muscle disorder that leads to severe muscle weakness and a drastically ...

A long-forgotten drug shows promise for children with a rare disease, offering hope for treatment where none previously ...

Myofibrillar myopathy type 6 (MFM6) is a rare genetic muscle disorder that leads to severe muscle weakness and a drastically shortened life expectancy due to a disruption in muscle protein regulation.

“I had to fight to be listened to,” the woman said ...

After the diagnosis, Manhasset's Lizz Yeh DiMaiolo and Bobby DiMaiolo founded the Rare Remy Foundation to fund research into ...

Researchers at the University Hospital Bonn have developed a humanized mouse model for myofibrillar myopathy type 6 (MFM6), revealing that impaired autophagy driven by a defective BAG3 protein leads ...

An Oregon veteran's 16-year fight with the VA over benefits for inclusion body myositis, or IBM, is part of a growing ...

A NEW screening test for two rare genetic conditions is now being offered to all newborn babies in Ireland, the Department of ...

The EMA has backed broader pediatric use of Agamree and Crysvita, lowering age thresholds for rare genetic diseases affecting muscle and bone development.

Dr Sudhir Kumar, neurologist, said that Hypokalemic Periodic Paralysis (HPP) is a rare genetic muscle disorder that affects ...